Cost-Effectiveness Analysis Of Insulin Degludec Versus Insulin Glargine U100 In Type 1 And Type 2 Diabetes Patients From The Portuguese National Healthcare System Perspective- Evidence From The Switch 12 Trials
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.465
https://www.valueinhealthjournal.com/article/S1098-3015(17)30799-4/fulltext
Title :
Cost-Effectiveness Analysis Of Insulin Degludec Versus Insulin Glargine U100 In Type 1 And Type 2 Diabetes Patients From The Portuguese National Healthcare System Perspective- Evidence From The Switch 12 Trials
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30799-4&doi=10.1016/j.jval.2017.08.465
First page :
A481
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
440